Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Neurocrit Care. 2020 Nov 4;35(1):30–38. doi: 10.1007/s12028-020-01136-6

Table 1.

Patient demographics and clinical characteristics (N=345).

All patients (N = 345) No vasospasm (N = 127) Vasospasm (N = 218) p-value
Age in years (mean (SD)) 54.5 (13.4) 57.2 (15.2) 52.9 (11.9) 0.004
Sex (n (%)) 0.325
Female 234 (68) 91 (72) 143 (66)
Male 111 (32) 36 (28) 75 (34)
Race (n (%))
White 269 (78) 92 (72) 177 (81) 0.203
Black 50 (15) 23 (18) 27 (12)
Other 26 (8) 12 (10) 14 (7)
Tobacco use (n (%)) 0.062
Yes 195 (57) 63 (50) 132 (61)
No 150 (43) 64 (50) 86 (39)
Fisher grade (n (%)) 0.003
1 6 (2) 5 (4) 1 (1)
2 29 (8) 13 (10) 16 (7)
3 57 (17) 29 (23) 28 (13)
4 253 (73) 80 (63) 173 (79)
Hunt-Hess grade (n (%)) 0.035
1 24 (7) 10 (8) 14 (6)
2 81 (24) 40 (32) 41 (19)
3 94 (27) 35 (28) 59 (27)
4 94 (27) 25 (20) 69 (32)
5 52 (15) 17 (13) 35 (16)
Initial treatment (n (%)) 0.283
Endovascular 277 (81) 107 (85) 170 (78)
Open surgery 59 (17) 16 (13) 43 (20)
Other 7 (2) 3 (2) 4 (2)
Nimodipine use (n (%)) 0.788
Yes 342 (99) 126 (99) 216 (99)
No 3 (1) 1 (1) 2 (1)
Maximum PaO2 (mean (SD)) 218.8 (117.3) 195.4 (101.0) 232.4 (124.1) 0.005
Minimum PaCO2 (mean (SD)) 34.1 (6.5) 34.8 (6.7) 33.7 (6.3) 0.100